Fadu head and neck squamous cell carcinoma induces hyperexcitability of primary sensory neurons in an in vitro coculture model

被引:4
|
作者
Uhelski, Megan L. [1 ]
Gorur, Aysegul [2 ,3 ]
Shi, Ted [2 ,3 ]
Corrales, German [2 ]
Du, Kim N. [4 ]
Li, Yan [1 ]
Amit, Moran [5 ]
Tatsui, Claudio E. [6 ]
Rhines, Laurence D. [6 ]
Dougherty, Patrick M. [1 ]
Cata, Juan P. [2 ,3 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Anesthesia & Pain Med Res, Houston, TX 77005 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, 1515 Holcombe Blvd,Unit 409, Houston, TX 77005 USA
[3] Anesthesiol & Surg Oncol Res Grp, Houston, TX USA
[4] Univ Texas Houston, McGovern Med Sch, Houston, TX USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77005 USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77005 USA
关键词
Perineural invasion; Dorsal root ganglia; Sensitization; ROOT GANGLION NEURONS; CANCER PAIN; MESSENGER-RNA; ORAL-CANCER; SPINAL-CORD; CONTRIBUTES; TOCILIZUMAB; ACTIVATION; INTERLEUKIN-6; AGE;
D O I
10.1097/PR9.0000000000001012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction: Currently, cancer pain is viewed as a process orchestrated by the release of pronociceptive molecules and the invasion of neural structures, referred to as perineural invasion (PNI). Cancer pain resulting from PNI is well-documented, but the mechanisms leading to peripheral sensitization because of tumor growth are not fully known. Methods: A retrospective study was used to examine how the use of anti-inflammatory medications affected preoperative pain in patients with oral squamous cell carcinoma cancer. We then used an in vitro coculture model in which dorsal root ganglion (DRG) neurons were incubated together with Fadu human head and neck squamous cell carcinoma cancer cells to explore how cancer cells affect the electrical membrane properties of sensory neurons. Results: We found that inflammation contributes to preoperative pain in patients with oral squamous cell carcinoma. After coculture with Fadu human head and neck squamous cell carcinoma cancer cells, we identified markers of inflammation in coculture media and found evidence of neuronal sensitization, including spontaneous activity, reduced current thresholds, depolarized resting membrane potential, and enhanced responses to current stimulation in human and rat DRG neurons. In rats, these effects were influenced by sex and age: neurons from young adult female rats were resistant to changes in neuronal activity, in contrast to neurons from older adult female rats or male rats of either age group. Conclusions: Pro-inflammatory substances released in cancer cell-DRG coculture promoted neuronal hyperexcitability and may contribute to cancer pain after PNI, and these effects may differ across age groups and sexes.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Concomitant chemoirradiation with vinorelbine and gefitinib induces additive effect in head and neck squamous cell carcinoma cell lines in vitro
    Erjala, Kaisa
    Zhang, Na
    Sundvall, Maria
    Kulmala, Jarmo
    Elenius, Klaus
    Grenman, Reidar
    RADIOTHERAPY AND ONCOLOGY, 2007, 85 (01) : 138 - 145
  • [32] Approach to the Patient with Unknown Primary Squamous Cell Carcinoma of the Head and Neck
    Moy, Jennifer
    Li, Ryan
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (12)
  • [33] Head and neck squamous cell carcinoma from an unknown primary site
    Wallace, Audrey
    Richards, Greg M.
    Harari, Paul M.
    Kirwan, Jessica M.
    Morris, Christopher G.
    Katakam, Haritha
    Mendenhall, William M.
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2011, 32 (04) : 286 - 290
  • [34] Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck
    Hung, Yu-Hsuan
    Liu, Shih-An
    Wang, Chen-Chi
    Wang, Ching-Ping
    Jiang, Rong-San
    Wu, Shang-Heng
    PLOS ONE, 2018, 13 (10):
  • [35] Approach to the Patient with Unknown Primary Squamous Cell Carcinoma of the Head and Neck
    Jennifer Moy
    Ryan Li
    Current Treatment Options in Oncology, 2020, 21
  • [36] Evaluation and Management of Head and Neck Squamous Cell Carcinoma of Unknown Primary
    Martin, Jeffrey M.
    Galloway, Thomas J.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 24 (03) : 579 - +
  • [37] Commentary on "Management of unknown primary head and neck squamous cell carcinoma"
    Mendenhall, William M.
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2012, 33 (05) : 638 - 639
  • [38] Prognostic factors of unknown primary head and neck squamous cell carcinoma
    Huang, Chun-Chi
    Tseng, Fen-Yu
    Yeh, Te-Huei
    Wen, Yu-Hsuan
    Hsu, Chuang-Jen
    Ko, Jeng-Yuh
    Lou, Pei-Jen
    Chen, Yuh-Shyang
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2008, 139 (03) : 429 - 435
  • [39] Squamous cell carcinoma from an unknown head and neck primary site
    Patel, Rajan S.
    Clark, Jonathan
    Wyten, Rebecca
    Gao, Kan
    O'Brien, Christopher J.
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2007, 133 (12) : 1282 - 1287
  • [40] Head and Neck Squamous Cell Carcinoma of Unknown Primary: Is There a Better Treatment?
    Nguyen, N.
    Hodson, D.
    Zhang, H.
    Doerwald-Munoz, L. E.
    Jim, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S570 - S570